{
  "company": {
    "name": "cTRL Therapeutics",
    "website": "https://ctrltherapeutics.com/",
    "record": "https://startuphistory.org/c/ctrltherapeutics.com"
  },
  "status": null,
  "history_since": null,
  "baseline": null,
  "live_captures": 0,
  "last_checked": null,
  "live_status": "offline",
  "messaging": [],
  "changes": [],
  "update": null,
  "same_space": [
    {
      "name": "Obsidian Therapeutics",
      "record": "https://startuphistory.org/c/obsidiantx.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both develop platforms enabling T‑cell or TIL‑based therapies for solid tumors."
    },
    {
      "name": "Eureka Therapeutics",
      "record": "https://startuphistory.org/c/eurekatherapeutics.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both work on engineered T‑cell therapies aimed at treating solid tumors."
    },
    {
      "name": "ImmunoScape",
      "record": "https://startuphistory.org/c/immunoscope.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both focus on TCR‑based cell therapies for solid tumors using specialized discovery platforms."
    },
    {
      "name": "TScan Therapeutics",
      "record": "https://startuphistory.org/c/tscan.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both are involved in TCR‑T cell therapies targeting solid tumors."
    }
  ],
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “cTRL Therapeutics” company record, https://startuphistory.org/c/ctrltherapeutics.com"
}